Skip to main content

#152631

Anti-NCAM [UJ13A]

Cat. #152631

Anti-NCAM [UJ13A]

Cat. #: 152631

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Neural Cell Adhesion Molecule (NCAM; CD56)

Class: Monoclonal

Application: IF ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: John Kemshead

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-NCAM [UJ13A]
  • Alternate name: Neural Cell Adhesion Molecule; NCAM; CD56 Antigen; MSK39
  • Research fields: Cell biology;Cell signaling and signal transduction;Neurobiology;Stem cell biology
  • Clone: UJ13A
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 180 kDa, 160 kDa, 120 kDa
  • Reactivity: Human
  • Host: Mouse
  • Application: IF ; WB
  • Description: NCAM, also known as CD56, is a homophillic binding glycoprotein present on a variety of neural cells including neurons, glia, skeletal muscle and natural killer cells. NCAM has been implicated as having a role in cell-cell adhesion, neurite outgrowth, synatptic plasticity, learning and memory and in the development of the nervous system.
  • Immunogen: 16 week human foetal brain
  • Isotype: IgG1

Target Details

  • Target: Neural Cell Adhesion Molecule (NCAM; CD56)
  • Molecular weight: 180 kDa, 160 kDa, 120 kDa
  • Target background: NCAM, also known as CD56, is a homophillic binding glycoprotein present on a variety of neural cells including neurons, glia, skeletal muscle and natural killer cells. NCAM has been implicated as having a role in cell-cell adhesion, neurite outgrowth, synatptic plasticity, learning and memory and in the development of the nervous system.

Applications

  • Application: IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Patel et al. 1989. Int J Cancer. 44(6):1062-8. PMID: 2558078.
  • Patel et al. 1989. Br J Cancer. 60(6):861-6. PMID: 2481486.
  • Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.
  • Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM).
  • Moss et al. 1988. Lung Cancer. 4, 76-78.
  • Allan et al. 1983. Int J Cancer. 31(5):591-8. PMID: 6852977.
  • Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.